abm drug discovery
Luciferase Stable IGR-N91 Cell Line | T6101
- SKU:
- T6101
- Availability:
- 5 to 7 Days Shipment
Description
abm | Luciferase Stable IGR-N91 Cell Line | T6101
Luciferase Stable IGR-N91 cells are derived from a bone marrow metastasis of a neuroblastoma with amplified MYCN gene amplification (a characteristic of advanced neuroblastoma). These cells have applications in understanding more about local and metastatic tumor growth patterns and exploring new cancer therapeutics.
Biosafety:
II
Organism:
Human (H. sapiens)
Source Organ:
Bone Marrow
Growth Properties:
Adherent
Morphology:
Epithelial
Clones:
N/A
Passage Number:
N/A
Population Doner:
36 - 48 hours
Seeding Density:
40,000 - 60,000 cells/cm2
Markers:
Luciferase (gene insertion), PcDNA3-Luc2 vector, neomycin resistance
Applications:
For Research Use Only
Doner Gender:
N/A
Donor Ethnicity:
Not disclosed
Knockdown Method:
N/A
Induction:
N/A
Overexpression:
N/A
Freeze Thaw:
N/A
Propagation:
The base medium for this cell line is Prigrow III medium available at abm
Preservation:
1. Freeze Medium: Complete growth medium with 20% FBS and 10% DMSO.
2. Storage Temperature: Liquid nitrogen vapour phase.
Quality Control:
1) Western blot; 2) Bioluminescence; 3) Inner salt (MTS) assay
Tumorgenicn:
N/A
Shipping Conditions:
Dry Ice
Storage Contidions:
-180°C